These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 6376230)

  • 21. [Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].
    Thivolet C; Khallouf E
    Pediatrie; 1989; 44(4):247-57. PubMed ID: 2677968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etiology and pathogenesis of insulin dependent diabetes mellitus.
    Skyler JS; Rabinovitch A
    Pediatr Ann; 1987 Sep; 16(9):682-3, 686-92. PubMed ID: 3309846
    [No Abstract]   [Full Text] [Related]  

  • 23. Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.
    Betterle C; Presotto F; Pedini B; Moro L; Slack RS; Zanette F; Zanchetta R
    Diabetologia; 1987 May; 30(5):292-7. PubMed ID: 3301480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selecting culprits in type 1 diabetes beta-cell killing.
    Lernmark A
    J Clin Invest; 1999 Dec; 104(11):1487-9. PubMed ID: 10587509
    [No Abstract]   [Full Text] [Related]  

  • 25. Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus.
    Foulis AK; Farquharson MA
    Diabetes; 1986 Nov; 35(11):1215-24. PubMed ID: 3530850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
    Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
    Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluctuating islet-cell autoimmunity in unaffected relatives of patients with insulin-dependent diabetes.
    Spencer KM; Tarn A; Dean BM; Lister J; Bottazzo GF
    Lancet; 1984 Apr; 1(8380):764-6. PubMed ID: 6143085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Class II HLA Genotype Association With First-Phase Insulin Response Is Explained by Islet Autoantibodies.
    Koskinen MK; Lempainen J; Löyttyniemi E; Helminen O; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Ilonen J; Toppari J; Veijola R
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2870-2878. PubMed ID: 29300921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Islet-cell antibodies in juvenile diabetes mellitus (author's transl)].
    Ludwig H; Schernthaner G; Mayr WR
    Dtsch Med Wochenschr; 1977 Aug; 102(34):1221-4. PubMed ID: 334498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunogenetic mechanisms in the pathogenesis of type 1 diabetes mellitus].
    Tatoń J; Czech A; Podgórski G
    Pol Tyg Lek; 1984 Aug; 39(34):1141-6. PubMed ID: 6390380
    [No Abstract]   [Full Text] [Related]  

  • 31. Addison's disease: immunological aspects.
    Latinne D; Vandeput Y; De Bruyere M; Bottazzo F; Sokal G; Crabbe J
    Tissue Antigens; 1987 Jul; 30(1):23-4. PubMed ID: 3118503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.
    Robles DT; Eisenbarth GS; Dailey NJ; Peterson LB; Wicker LS
    Diabetes; 2003 Mar; 52(3):882-6. PubMed ID: 12606534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DR antigen frequencies in a North Indian type I diabetic population.
    Bhatia E; Mehra NK; Taneja V; Vaidya MC; Ahuja MM
    Diabetes; 1985 Jun; 34(6):565-7. PubMed ID: 3891468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An explanation for the protective effect of the MHC class II I-E molecule in murine diabetes.
    Reich EP; Sherwin RS; Kanagawa O; Janeway CA
    Nature; 1989 Sep; 341(6240):326-8. PubMed ID: 2507922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.
    Drell DW; Notkins AL
    Diabetologia; 1987 Mar; 30(3):132-43. PubMed ID: 3556288
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunopathological and genetic features in slowly progressive insulin-dependent diabetes mellitus and latent autoimmune diabetes in adults.
    Kobayashi T; Tanaka S; Harii N; Aida K; Shimura H; Ohmori M; Kanesige M; Shimada A; Maruyama T
    Ann N Y Acad Sci; 2006 Oct; 1079():60-6. PubMed ID: 17130533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet-cell and insulin autoantibodies in first-degree relatives of type I diabetics: a 5-year follow-up study in a Swiss population.
    Spinas GA; Matter L; Wilkin T; Staffelbach O; Berger W
    Adv Exp Med Biol; 1988; 246():209-14. PubMed ID: 3074652
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
    Kehr S; Gastauer R; Winkler G
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):738-42. PubMed ID: 3906379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Type 1 diabetes mellitus, autoimmune disease: physiopathologic aspects and practical applications].
    Timsit J; Boitard C; Bach JF
    Ann Biol Clin (Paris); 1991; 49(3):149-53. PubMed ID: 2064084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pathogenesis of insulin-dependent (type I) diabetes mellitus].
    Weber B
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):355-63. PubMed ID: 2931586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.